CN1799639A - Inflammation-eliminating, pain-stopping, bacteria-resisting, pain-relieving soluble hemostatic gauze and its processing method - Google Patents
Inflammation-eliminating, pain-stopping, bacteria-resisting, pain-relieving soluble hemostatic gauze and its processing method Download PDFInfo
- Publication number
- CN1799639A CN1799639A CN 200510135361 CN200510135361A CN1799639A CN 1799639 A CN1799639 A CN 1799639A CN 200510135361 CN200510135361 CN 200510135361 CN 200510135361 A CN200510135361 A CN 200510135361A CN 1799639 A CN1799639 A CN 1799639A
- Authority
- CN
- China
- Prior art keywords
- gauze
- pain
- soluble stanching
- soluble
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002439 hemostatic effect Effects 0.000 title abstract description 9
- 206010061218 Inflammation Diseases 0.000 title abstract description 4
- 238000003672 processing method Methods 0.000 title description 8
- 230000003115 biocidal effect Effects 0.000 claims abstract description 21
- 230000036407 pain Effects 0.000 claims abstract description 15
- 239000000126 substance Substances 0.000 claims abstract description 13
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 12
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims abstract description 12
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims abstract description 12
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 11
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229940008099 dimethicone Drugs 0.000 claims abstract description 11
- 239000004205 dimethyl polysiloxane Substances 0.000 claims abstract description 11
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims abstract description 11
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims abstract description 11
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims abstract description 11
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 11
- 239000000661 sodium alginate Substances 0.000 claims abstract description 11
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 11
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 11
- 239000000047 product Substances 0.000 claims description 26
- 230000000202 analgesic effect Effects 0.000 claims description 23
- 230000000844 anti-bacterial effect Effects 0.000 claims description 18
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 17
- 229940088710 antibiotic agent Drugs 0.000 claims description 14
- 235000001014 amino acid Nutrition 0.000 claims description 13
- 150000001413 amino acids Chemical class 0.000 claims description 13
- 230000001476 alcoholic effect Effects 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 11
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 10
- 229920002125 Sokalan® Polymers 0.000 claims description 10
- 229960001631 carbomer Drugs 0.000 claims description 10
- 235000019800 disodium phosphate Nutrition 0.000 claims description 10
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 claims description 5
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 5
- 229920000153 Povidone-iodine Polymers 0.000 claims description 5
- 229960005274 benzocaine Drugs 0.000 claims description 5
- 229960003260 chlorhexidine Drugs 0.000 claims description 5
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 5
- 229920000136 polysorbate Polymers 0.000 claims description 5
- 229920000053 polysorbate 80 Polymers 0.000 claims description 5
- 229960001621 povidone-iodine Drugs 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000011265 semifinished product Substances 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 17
- 230000029663 wound healing Effects 0.000 abstract description 6
- 238000000034 method Methods 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 238000001356 surgical procedure Methods 0.000 abstract description 2
- 229940099544 americaine Drugs 0.000 abstract 1
- 229940124350 antibacterial drug Drugs 0.000 abstract 1
- 229940061607 dibasic sodium phosphate Drugs 0.000 abstract 1
- 230000004083 survival effect Effects 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 description 19
- 208000027418 Wounds and injury Diseases 0.000 description 19
- 239000000243 solution Substances 0.000 description 15
- 230000035876 healing Effects 0.000 description 13
- 238000012360 testing method Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 208000031737 Tissue Adhesions Diseases 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 5
- 238000001035 drying Methods 0.000 description 4
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 4
- 229930185107 quinolinone Natural products 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 108090000190 Thrombin Proteins 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 229960004072 thrombin Drugs 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000005214 Poroma Diseases 0.000 description 1
- GBFLZEXEOZUWRN-VKHMYHEASA-N S-carboxymethyl-L-cysteine Chemical compound OC(=O)[C@@H](N)CSCC(O)=O GBFLZEXEOZUWRN-VKHMYHEASA-N 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- -1 carboxymethyl ester Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000001013 eccrine acrospiroma Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Abstract
A soluble hemostatic gauze for anti-inflammation and pain relieving and the preparing method, relating to field of medical sanitary goods. The hemostatic gauze comprises the following substance according to the percentage by weight: dibasic sodium phosphate 0.1-0.3%, sodium alginate 1-1.8%, carbomu 0.5-25, antibacterial drugs 1-10%, polyethylene glycol 1-2%, tuwen 1-4%, dimethicone 0.1-1%, sodium carboxymethylcellulose 0.2-0.8%, americaine 0.05% and the left is ethanol solution. The product possesses functions of special pain relieving, preventing adhesion after surgery besides functions of hemostatic, broad spectrum antibiotic and promoting wound healing, which is of great importance for relieving patient pain and improving their survival quality.
Description
Technical field
A kind of antiinflammatory, pain relieving, antibiotic analgesic Solubility Hemostatic Gauze and Processing Method relate to the medical and hygiene article field.
Background technology
Present hospital gauze generally be by comprehensive fiber through spin, knit, defat, bleaching, dry, disinfect after, use for medical department, such gauze becomes the waste pollution environment after using, simultaneously after the wound incrustation, gauze can bond with wound, cause the secondary wound easily for taking off gauze when changing dressings, bring misery, be unfavorable for the timely healing of wound to the patient.Based on above-mentioned problem, people have invented soluble stanching gauze.Soluble stanching gauze is generally the product after the opposite fiber carries out defat and mystery processing, promptly pass through C, M, the NA content that the general method for making of C is made is at the SCMC of 6-8% (sodium carboxymethyl cellulose), as the Chinese patent patent No. is 91110511 and 98101676, soluble stanching gauze is clogged after the dipping antimicrobial treatment, cover various wounds, solubilized conclusion of the business shape thing behind the liquid that the chance wound oozes out, produce a large amount of anion, play the activation thrombin, promote the generation of thrombin, platelet is condensed rapidly, stifled match blood capillary, thus play hemostasis, protect wound, protect from infection, promote the effect of wound healing.But the function of this soluble stanching gauze antibiotic and sterilizing is relatively poor, can not solve the problem of tissue adhesion.
A kind of antiinflammatory, antibiotic external used synthesized medicine, Solubility Hemostatic Gauze and Processing Method have been introduced among the Chinese patent ZL02135172.4, this synthetic drug is the chemical compound that quinolinones and aminoacid reaction back forms, and soluble anti-inflammation, antibiotic, hemostatic gauze comprise the chemical compound of soluble fiber and quinolinones and aminoacid reaction back formation; Soluble anti-inflammation, processing method antibiotic, hemostatic gauze comprise the following order step: (1) aminoacid and quinolinones are adjusted concentration to 5～30% (weight) in aqueous solution or ethanol water, react 0.5～30 hour; (2) reactant in the step (1) was mixed in the alcoholic solution of 80～95% (weight) 0.5～30 hour by 1: 2～10 (weight ratios) with soluble fiber; (3) soluble fiber is taken out drying in solution.Wound site can directly be clogged, be covered to this gauze, and discharge monomer quinolinones and amino acid nutrient composition at wound, causes the secondary wound at the Shi Buhui that changes dressings, and wound healing is fast.But it is very stable and balanced that medicine and combining of soluble stanching gauze are not, medicine be not molecular structure with the best attached on the soluble stanching gauze, make the effect of disinfection not bring into play fully.
In addition, a kind of view is arranged in the prior art, think that the external application of analgesic has disadvantageous effect for the healing of wound, so prior art is generally with oral or injection analgesic.Wherein have a kind of viewpoint to think that analgesic benumbed peripheral nerve, human body can not in time be made a response to wound information like this, influences the reparation of wound; Also have a kind of viewpoint to think, the generation of the pair cell of analgesic own is influential, thereby influences the healing of wound.
Summary of the invention
An object of the present invention is for the function that solves soluble stanching gauze antibiotic and sterilizing in the above-mentioned prior art relatively poor, medicine is not that molecular structure with the best is attached on the soluble stanching gauze, make the effect of disinfection not bring into play fully, there is not analgesic activity, can not solve the problem of tissue adhesion, a kind of antiinflammatory, pain relieving, antibiotic analgesic soluble stanching gauze are provided.
Another object of the present invention provides the preparation method of a kind of antiinflammatory, pain relieving, antibiotic analgesic soluble stanching gauze.
For achieving the above object, a technical scheme of the present invention provides a kind of antiinflammatory, pain relieving, antibiotic analgesic soluble stanching gauze, constitute the sodium hydrogen phosphate of 0.1-0.3%, the sodium alginate of 1-1.8%, the carbomer of 0.5-2% by the material of following weight percentage ratio, the antibacterials of 1-10%, the Polyethylene Glycol of 1-2%, 1-4% tween 80,0.1-1% dimethicone, 0.2-0.8% sodium carboxymethyl cellulose, all the other are concentration greater than 80% alcoholic solution for 0.05% benzocaine.
Described antibacterials are the complex of povidone iodine and chlorhexidine, and wherein, the part by weight of povidone iodine and chlorhexidine is 4: 1, reaction condition is for being under the condition of 3-6.9 at pH, and adding weight percentage is the zinc oxide of 0.2-0.8%, boiling reflux 1-8 hour.
The optimization formula of a kind of antiinflammatory of the present invention, pain relieving, antibiotic analgesic soluble stanching gauze: the material by following weight percentage ratio constitutes: the carbomer of 0.2% sodium hydrogen phosphate, the sodium alginate of 1.2-1.6%, 1-1.5%, the antibacterials of 5-8%, the Polyethylene Glycol of 1.2-1.8%, 2-3% tween 80,0.4-0.6% dimethicone, 0.4-0.6% sodium carboxymethyl cellulose, 0.05% benzocaine, all the other are the alcoholic solution of 85-95% for concentration.
The aminoacid that can also comprise 0-0.05% among the present invention.Described aminoacid is aminoacid of the prior art, as tryptophan, methionine, threonine, leucine, valine, phenylalanine etc.; Optimum ratio 0.01-0.02%.
For achieving the above object, another technical scheme of the present invention provides the preparation method of a kind of antiinflammatory, pain relieving, antibiotic analgesic soluble stanching gauze.
Configuration concentration is the alcoholic solution more than 80%, add sodium hydrogen phosphate, sodium alginate, carbomer, add antibacterials then, elevated temperature is to 45-85 ℃, stir, add soluble stanching gauze, stir or the condition of ultrasonic vibrations under carry out dynamic chemical and take out gauze after in conjunction with 0.5-60 hour, continuous Polyethylene Glycol, tween 80, dimethicone, the sodium carboxymethyl cellulose that adds in original liquid, the semi-finished product gauze is put into medicinal liquid, proceed dynamic chemical in conjunction with 1-30 hour under 45-85 ℃, take out, the drying with steam oven dry gets product.
Say the preparation method of a kind of antiinflammatory of the present invention, pain relieving, antibiotic analgesic soluble stanching gauze further.
Configuration concentration is the alcoholic solution of 85-95%, add sodium hydrogen phosphate, sodium alginate, carbomer, add antibacterials then, elevated temperature is to 50-70 ℃, stir, add soluble stanching gauze, stir or the condition of ultrasonic vibrations under carry out dynamic chemical and take out gauze after in conjunction with 4-12 hour, continuous Polyethylene Glycol, tween 80, dimethicone, the sodium carboxymethyl cellulose of adding in original liquid, the semi-finished product gauze is put into medicinal liquid, proceed dynamic chemical in conjunction with 4-12 hour under 45-85 ℃, take out, drying with steam gets product.
Further say the preparation method of a kind of antiinflammatory of the present invention, pain relieving, antibiotic analgesic soluble stanching gauze.
Configuration concentration is the alcoholic solution of 90-95%, add aminoacid, elevated temperature is to 50-60 ℃, the glycerol that adds 0.1-0.5%, add antibacterials, the adjusting pH value is 8-12, boiling reflux 2-3 hour, add sodium hydrogen phosphate then, sodium alginate, carbomer, elevated temperature stirs to 50-60 ℃, add soluble stanching gauze, after dynamic chemical under the condition of stirring or ultrasonic vibrations was in conjunction with 4-8 hour, take out gauze, the continuous Polyethylene Glycol that adds in original liquid, tween 80, dimethicone, sodium carboxymethyl cellulose is put into medicinal liquid with the semi-finished product gauze, the adjusting pH value is 3-6.8, proceed dynamic chemical in conjunction with 4-8 hour under 50-60 ℃, take out, oven dry gets product.
Beneficial effect:
Product of the present invention is compared with prior art products:
1. this product has antiseized, sterilization, antiinflammatory, stops blooding and certain debridement effect is arranged wound.
2. this product combines many combinations complex of antibacterials thing and analgesic drug product for being carrier with the fiber carboxymethyl ester, and all the other products are one pack system in the prior art.
3. this product is except that possessing hemostasis at once, broad-spectrum antiseptic, promotion wound healing, also possesses unique pain relieving, prevents the function of tissue adhesion.This function is for reducing the patient suffering, and it is significant undoubtedly to improve patient's life quality.
4. because soluble stanching gauze is loose porous material, can the chemical bond said medicine, said medicine has suitable molecular structure in certain ph value and certain solution environmental in addition, can with soluble stanching gauze by electrostatic attraction and combination, so can realize the quantitative chemical combination.Reach excellent sterilization, sterilization, analgesic effect.
Disinfectant for external use such as povidone iodine and chlorhexidine with can bring into play synergism after soluble stanching gauze combines, make product of the present invention wider than the antimicrobial spectrum of prior art, antibacterial activity is stronger, can reduce the side effect of local analgesia agent simultaneously.This point infects prevention and treatment and alleviates the patient suffering simultaneously and have important function undoubtedly.Povidone iodine and chlorhexidine make product dissolving of the present invention back be easier to make antibacterials to separate from gauze under the attack of hydrone with the combination of gauze in addition, thereby can better bring into play antibacterial action.
6. added aminoacid is one of necessary aminoacid of human body, provides essential nutritional labeling for promoting tissue repair and wound healing.Therefore add this product behind the aminoacid and have the effect of significant promotion wound healing.
The specific embodiment
Enumerate embodiment below, the present invention is further specified, but the present invention is not only limited to these embodiment.
Embodiment 1
Configuration concentration is 85% alcoholic solution, the sodium hydrogen phosphate that adds 0.2kg, 1.5kg sodium alginate, the carbomer of 1kg, the antibacterials that add 6kg then, elevated temperature is to 45-85 ℃, stir, add soluble stanching gauze, stir or the condition of ultrasonic vibrations under carry out dynamic chemical and take out gauze after in conjunction with 1-30 hour, the continuous Polyethylene Glycol that adds 1.5kg in original liquid, the 3kg tween 80,0.5kg dimethicone, 0.5kg sodium carboxymethyl cellulose, the semi-finished product gauze is put into medicinal liquid, proceed dynamic chemical in conjunction with 5-25 hour under 45-85 ℃, take out, the drying with steam oven dry gets product.
Embodiment 2-6
Prepare a kind of antiinflammatory, pain relieving, antibiotic analgesic soluble stanching gauze, raw materials used and proportioning such as following table according to embodiment 1 described method
| Embodiment 2 | Embodiment 3 | Embodiment 4 | Embodiment 5 | Embodiment 6 | |
| Sodium hydrogen phosphate | 0.1 | 0.15 | 0.3 | 0.25 | 0.2 |
| Sodium alginate | 1.5 | 1.2 | 1 | 1.8 | 1.6 |
| Carbomer | 1.3 | 0.5 | 2 | 1.5 | 1 |
| Antibacterials | 10 | 5 | 8 | 1 | 6 |
| Polyethylene Glycol | 2 | 1.2 | 1.8 | 1.5 | 1 |
| Tween 80 | 2 | 1 | 4 | 3 | 2.5 |
| Dimethicone | 0.4 | 0.6 | 0.1 | 1 | 0.5 |
| Sodium carboxymethyl cellulose | 0.8 | 0.4 | 0.6 | 0.2 | 0.5 |
| Benzocaine | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Aminoacid | 0 | Tryptophan 0.01 | Methionine 0.02 | Threonine 0.05 | Leucine 0.01 |
| Alcoholic solution | Concentration 85% ethanol | Concentration 90% ethanol | Concentration 95% ethanol | Concentration 80% ethanol | Concentration 85% ethanol |
| Solution 81.85 | Solution 89.89 | Solution 82.13 | Solution 89.85 | Solution 86.64 |
The product of the embodiment of the invention 1 is carried out the zoopery contrast with the product that obtains the processing method production of introducing among the Chinese patent ZL02135172.4 of domestic patent, 80 of choosing test rats, random packet, test group and matched group are 40 examples, skin to back 2*2cm after test group and the control rats unhairing carries out aseptic process, two groups of rats all alternately inoculate the positive bacteria in the same culture dish at random, test group is carried out antibacterial therapy with this patent product then, and matched group uses the product of the processing method production of introducing among the Chinese patent ZL02135172.4 of same area to treat.Test the healing state of observing wound surface after three days.To the evaluation of healing state, according to surgery evaluation methodology commonly used: it is good that first class healing, wound do not have red and swollen healing; The second class healing, wound circumference has redness or poroma, but does not have suppuration; The third class healing, wound is suppurative infection.Add up the case load of two treated animal first, second, the third three grades of healings respectively.Heal as the good evaluation criterion of Disinfection Effect with first class.Experimental result is as follows:
| Group | The first class healing | The second class healing | The third class healing |
| Test group | 40(100％) | 0 | 0 |
| Matched group | 30(75) | 0 | 0 |
Above-mentioned data are carried out statistical procedures with X 2 test.Compare P＜0.05 between group, this patent product is compared antibacterial effect with the matched group product the significance progress.
The product of the embodiment of the invention 1 is carried out the zoopery contrast with having obtained the product that the processing method introduced among the Chinese patent ZL02135172.4 of domestic patent produces, find that this product is in analgesia with prevent from all to compare according to set product aspect the tissue adhesion marked improvement (P＜0.05) is arranged.Experimental result is as follows:
| Group | Analgesic effect is good | Analgesic effect is poor |
| Test group | 40(100％) | 0 |
| Matched group | 0(100％) | 40 |
| Group | Tissue adhesion example number | No tissue adhesion example number |
| Test group | 0 | 39(97.5％) |
| Matched group | 15 | 25(62.5％) |
Claims (5)
1. an antiinflammatory, pain relieving, antibiotic analgesic soluble stanching gauze, constitute the sodium hydrogen phosphate of 0.1-0.3%, the sodium alginate of 1-1.8%, the carbomer of 0.5-2% by the material of following weight percentage ratio, the antibacterials of 1-10%, the Polyethylene Glycol of 1-2%, 1-4% tween 80,0.1-1% dimethicone, 0.2-0.8% sodium carboxymethyl cellulose, 0.05% benzocaine, all the other are alcoholic solution more than 80% for concentration.
2. antiinflammatory according to claim 1, antibiotic analgesic soluble stanching gauze is characterized in that described antibacterials are the complex of povidone iodine and chlorhexidine.
3. antiinflammatory according to claim 1, antibiotic analgesic soluble stanching gauze, it is characterized in that, material by following weight percentage ratio constitutes: the carbomer of 0.2% sodium hydrogen phosphate, the sodium alginate of 1.2-1.6%, 1-1.5%, the antibacterials of 5-8%, the Polyethylene Glycol of 1.2-1.8%, 2-3% tween 80,0.4-0.6% dimethicone, 0.4-0.6% sodium carboxymethyl cellulose, 0.05% benzocaine, all the other are the alcoholic solution of 85-95% for concentration.
4. antiinflammatory according to claim 1, antibiotic analgesic soluble stanching gauze is characterized in that, also comprise the aminoacid of 0-0.05%.
5. the preparation method of antiinflammatory according to claim 1, antibiotic analgesic soluble stanching gauze:
Configuration concentration is the alcoholic solution more than 80%, add sodium hydrogen phosphate, sodium alginate, carbomer, add antibacterials then, elevated temperature is to 45-85 ℃, stir, add soluble stanching gauze, after dynamic chemical under the condition of stirring or ultrasonic vibrations was in conjunction with 0.5-60 hour, take out gauze, continuous Polyethylene Glycol, tween 80, dimethicone, the sodium carboxymethyl cellulose of adding in original liquid, the semi-finished product gauze is put into medicinal liquid, proceed dynamic chemical in conjunction with 1-30 hour under 45-85 ℃, take out, oven dry gets product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101353618A CN100379465C (en) | 2005-12-31 | 2005-12-31 | Inflammation-eliminating, pain-stopping, bacteria-resisting, pain-relieving soluble hemostatic gauze and its processing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101353618A CN100379465C (en) | 2005-12-31 | 2005-12-31 | Inflammation-eliminating, pain-stopping, bacteria-resisting, pain-relieving soluble hemostatic gauze and its processing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1799639A true CN1799639A (en) | 2006-07-12 |
| CN100379465C CN100379465C (en) | 2008-04-09 |
Family
ID=36809997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005101353618A Active CN100379465C (en) | 2005-12-31 | 2005-12-31 | Inflammation-eliminating, pain-stopping, bacteria-resisting, pain-relieving soluble hemostatic gauze and its processing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100379465C (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101450221A (en) * | 2007-11-30 | 2009-06-10 | 张博 | Soluble absorbable hemostasia products based on modified viscose fiber and preparation method thereof |
| CN101284144B (en) * | 2008-05-30 | 2011-06-08 | 上海爱灵卫生材料有限公司 | Soluble hemostatic cotton |
| CN103611185A (en) * | 2013-12-03 | 2014-03-05 | 安徽缘远博爱生物技术有限公司 | Antiseptic radix sophorae flavescentis soluble hemostatic gauze |
| CN103623459A (en) * | 2013-12-03 | 2014-03-12 | 安徽缘远博爱生物技术有限公司 | Dissoluble hemostatic gauze for sterilizing, diminishing inflammation and promoting granulation |
| CN103623461A (en) * | 2013-12-03 | 2014-03-12 | 安徽缘远博爱生物技术有限公司 | Soluble hemostatic gauze with functions of antisepsis and anti-inflammation |
| CN103623458A (en) * | 2013-12-03 | 2014-03-12 | 安徽缘远博爱生物技术有限公司 | Pseudo-ginsheng blood circulation and healing promoting water-soluble hemostatic gauze |
| CN104383586A (en) * | 2014-12-01 | 2015-03-04 | 哈尔滨工业大学 | Nanogold/lysine/oxidized regenerated cellulose composite hemostatic material and preparation method thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1045354A (en) * | 1989-03-10 | 1990-09-19 | 铁汉 | Non-adhesive gauze for reducing inflammation and accelerating recovery |
| US20030175328A1 (en) * | 2002-03-06 | 2003-09-18 | Adi Shefer | Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin |
| CN1190196C (en) * | 2002-07-11 | 2005-02-23 | 张博 | Anti-inflammation antibiotic external used synthesized medicine, soluble hemostatic gauze and method for making the same |
-
2005
- 2005-12-31 CN CNB2005101353618A patent/CN100379465C/en active Active
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101450221A (en) * | 2007-11-30 | 2009-06-10 | 张博 | Soluble absorbable hemostasia products based on modified viscose fiber and preparation method thereof |
| CN101284144B (en) * | 2008-05-30 | 2011-06-08 | 上海爱灵卫生材料有限公司 | Soluble hemostatic cotton |
| CN103611185A (en) * | 2013-12-03 | 2014-03-05 | 安徽缘远博爱生物技术有限公司 | Antiseptic radix sophorae flavescentis soluble hemostatic gauze |
| CN103623459A (en) * | 2013-12-03 | 2014-03-12 | 安徽缘远博爱生物技术有限公司 | Dissoluble hemostatic gauze for sterilizing, diminishing inflammation and promoting granulation |
| CN103623461A (en) * | 2013-12-03 | 2014-03-12 | 安徽缘远博爱生物技术有限公司 | Soluble hemostatic gauze with functions of antisepsis and anti-inflammation |
| CN103623458A (en) * | 2013-12-03 | 2014-03-12 | 安徽缘远博爱生物技术有限公司 | Pseudo-ginsheng blood circulation and healing promoting water-soluble hemostatic gauze |
| CN103623458B (en) * | 2013-12-03 | 2016-02-24 | 安徽缘远博爱生物技术有限公司 | A kind of pseudo-ginseng blood-circulation-invigovating promoting healing water-soluble hemostatic gauze |
| CN103623459B (en) * | 2013-12-03 | 2016-02-24 | 安徽缘远博爱生物技术有限公司 | A kind of soluble stanching gauze of germicidal anti-inflammatory myogenic |
| CN103611185B (en) * | 2013-12-03 | 2016-02-24 | 安徽缘远博爱生物技术有限公司 | A kind of Radix Sophorae Flavescentis sterilization soluble stanching gauze |
| CN104383586A (en) * | 2014-12-01 | 2015-03-04 | 哈尔滨工业大学 | Nanogold/lysine/oxidized regenerated cellulose composite hemostatic material and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100379465C (en) | 2008-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100471528C (en) | Liquid wound-dressing with functions of promoting heal of wound and bacterial-resisting | |
| CN100379465C (en) | Inflammation-eliminating, pain-stopping, bacteria-resisting, pain-relieving soluble hemostatic gauze and its processing method | |
| US9833539B2 (en) | E-polylysine hydrogel and preparation method and application thereof | |
| CN101829320A (en) | Collagen gel and preparation method thereof | |
| CN103083712A (en) | Stem cells or other bioactive substances doped surgical dressing | |
| CN111068103B (en) | Long-acting antibacterial gel dressing for operation wound and preparation method thereof | |
| CN1285339C (en) | Adhesive bandage containing hyaluronic acid biological composition | |
| CN107617121A (en) | A kind of skin wound biology induced activity dressing and its preparation method and application | |
| CN111150838A (en) | Collagen hydrogel for promoting wound healing and preparation method thereof | |
| CN103495174B (en) | Be used for the treatment of Multi-effect external preparation of Dermal skin damage and uses thereof | |
| CN100379464C (en) | Soluble hemostatic gauze for diminishing inflammation, killing bacteria and calming pain, and its making method | |
| CN111166932B (en) | Liquid wound spray dressing and preparation method thereof | |
| CN111632188A (en) | Seaweed polysaccharide composite biological matrix dressing and preparation method thereof | |
| CN113018499A (en) | Preparation method of ozone oil-water gel composite application capable of sterilizing, resisting virus and absorbing moisture | |
| CN111991417A (en) | Hypochlorous acid gel with physiological responsiveness and application thereof in skin wound surface | |
| CN103316330A (en) | Formula and purposes of soft tissue trauma nursing material | |
| CN102526121B (en) | Wound repair composition and preparation method and application thereof | |
| CN112675199B (en) | Drug combination and application thereof | |
| CN109395068A (en) | A kind of refractory wound Special sterilizing liquid | |
| CN101816678A (en) | Broad-spectrum contact type hemostatic medical fungicide and preparation method thereof | |
| US20200138851A1 (en) | Film for topical application in the treatment of skin lesions and method of obtaining and applying same | |
| CN103721248A (en) | Chitosan oral mucosa ulcer patch | |
| CN107595819B (en) | A kind of Nano diamond modified liquid adhesive bandage and preparation method thereof | |
| CN1190196C (en) | Anti-inflammation antibiotic external used synthesized medicine, soluble hemostatic gauze and method for making the same | |
| CN106955291B (en) | A kind of antibacterial anti-inflammatory medicament and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Qingdao Etsong Bioengineering Co., Ltd. Assignor: Zhang Bo Contract fulfillment period: 2008.11.6 to 2025.12.30 Contract record no.: 2008370000209 Denomination of invention: Inflammation-eliminating, pain-stopping, bacteria-resisting, pain-relieving soluble hemostatic gauze and its processing method Granted publication date: 20080409 License type: Exclusive license Record date: 20081219 |
|
| LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.11.6 TO 2025.12.30; CHANGE OF CONTRACT Name of requester: QINGDAO YIZHONG BIOLOGY ENGINEERING CO., LTD. Effective date: 20081219 |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Zhang Bo Document name: Notification to Pay the Fees |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Zhang Bo Document name: Notification of Termination of Patent Right |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210728 Address after: 266000 No. 592-16, jiushui East Road, Laoshan District, Qingdao City, Shandong Province Patentee after: Qingdao Zhonghui Shengxi Bioengineering Co.,Ltd. Address before: Donghai West Road 266071 Shandong city of Qingdao province No. 35 unit 13 C households Patentee before: Zhang Bo |